Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study.

Category Primary study
JournalJournal of Clinical Oncology
Year 2007
This article has no abstract
Epistemonikos ID: 19d3845b89ee245f0ca265325da8f015955793e6
First added on: Apr 04, 2025